Published: 2016-12-18

Pre-emptive gabapentin for postoperative pain relief in abdominal hysterectomy

Shailendra Deochandra Modak, Jyoti Magar, Vinayak Kakad


Background: The relief of pain has always been a part of the anaesthesiologist’s role in the most immediate postoperative period and the development of acute postoperative pain services has extended this interest beyond the post-anaesthesia care unit. The present study was carried out to evaluate the effects of preoperative oral gabapentin (600 mg) on postoperative pain relief, postoperative analgesic requirement and side effects in patients undergoing abdominal hysterectomy.

Methods: This prospective randomized placebo controlled study was conducted amongst sixty female patients of ASA grade I and II, age between 25-70 years, randomly allocated into two groups to receive either oral capsule gabapentin (600 mg) or placebo in the form of capsule multivitamin two hours prior to the surgery. Patients were observed 12 hours postoperatively for pain via visual analog scale (VAS), analgesic requirement and side effects.

Results: It was observed that patients in gabapentin group had statistically significant lower pain score during the entire observation period in comparison to placebo group. The mean number of rescue analgesic dose requirement in the gabapentin group (2.1±0.64) was substantially lower than that of the control group (4.3±0.88). The mean sedation scores were always higher in gabapentin group as compared to control group. Two patients in gabapentin group developed dizziness for a short duration and subsided by using ondensetron and required no further intervention.

Conclusions: Gabapentin significantly reduces post-operative pain and post-operative tramadol consumption with very few side effects.


Gabapentin, Post-operative pain, Pre-emptive analgesia, Abdominal hysterectomy

Full Text:



Morgan GE, Mikhail MS, Murray MJ, eds. Pain management. In: Clinical Anesthesiology. New York: Lange Medical Books. 2002:309-358.

Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, et al. Gabapentin for symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. J Am Med Asso. 1998;280:1831-6.

Rice AS, Maton S. Postherpetic neuralgia study group. gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain. 2001;94:215-24.

Dierking G, Duedahl TH, Rasmussen ML, Fomsgaard JS, Moiniche S, Romsing J, et al. Effects of gabapentin on postoperative morphine consumption and pain after abdominal hysterectomy: a randomized, double blind trial. Acta Anaesthesiol Scand. 2004;48:322-7.

Turan A, Karamanliolu B, Memi D, Usar P, Pamukcu Z, Ture M. The analgesic effects of gabapentin after total abdominal hysterectomy. Anesth Analg. 2004;98:1370-3.

Pandey CK, Priye S, Singh S, Singh U, Singh RB, Singh PK. Preemptive use of gabapentin significantly decreases postoperative pain and rescue analgesic requirements in laparoscopic cholecystectomy: a randomized, double-blind, placebo controlled study. Can J Anaesth. 2004;51:358-63.

Turan A, Karamanliolu B, Memi D, Hamamcioglu MK, Tukenmez B, Pamukcu Z, et al. The analgesic effects of gabapentin after spinal surgery: a randomized, double blind, placebo controlled trial. Anesthesiology. 2004;100:935-8.

Turan A, Memi D, Karamanliolu B, Yaiz R, Pamukcu Z, Yavuz E. The analgesic effects of gabapentin in monitored anesthesia care for ear-nose-throat surgery: a randomized controlled trial. Anesth Analg. 2004;99:375-8.

Woolf CJ, Chong MS. Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg. 1993;77:362-79.

Timothy JB, Peter KZ, Esther M. Pogatzki Z. Mechanisms of incisional pain. Anesthesiology Clin N Am. 2005;23:1-20.

Charles P. Taylor, Timothy Angelotti, Eric Faumanc Pharmacology and mechanism of action of pregabalin: The calcium channel subunit as a target for antiepileptic drug discovery. Epilepsy Research 2007;73:137-50.

Fassoulaki A, Triga A, Meleemeni A, Sarantopolous C. Multimodal analgesia with gabapentin and local anesthesia prevents acute and chronic pain after breast surgery for cancer. Anaesth Analg. 2005;101:427-32.

Pandey CK, Priya S, Singh S, Singh U, Singh RB, Singh PK. Preemptive use of gabapentin significantly decreases postoperative pain and rescue analgesic requirements in laparoscopic cholecystectomy. Can J Anesth. 2004;51:358-63.

Dirks J, Fredensborg BB, Christensen D, Fomsgaard JS, Flyger H, Dahl JB. A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology. 2002;97:560-4.

Durmus M, Kadir A, Saricicek V. The postoperative analgesic effects of a combination of gabapentin and paracetamol in patients undergoing abdominal hysterectomy: a randomised clinical trial. Acta Anaesthesia Scand. 2007;51(3);299-304.

Turan A, Karamanlioglu B, Memis D, Usar P, Pamukcu Z, Ture M. The analgesic effects of gabapentin after total abdominal hysterectomy. Anesth Analg. 2004;98:1370-3.

Menigaux, Adam F, Guignard B, Sessler DI, Chauvin M. Preoperative gabapentin decreases anxiety and improves early functional recovery from knee surgery. Anesth Analg. 2005;100:1394-9.

Mujadi, Refai, Katzarov MG, Dehrab NA,Batra YK, Qattan. Preemptive gabapentin reduces postoperative pain and opioid demand following thyroid surgery. Can J Anesth. 2006;53;268-73.

Bartholdy J, Hilsted KL, Hjortsoe NC, Engbaek J Dahl J. Effect of gabapentin on morphine demand and pain after laparoscopic sterilization using filshie clips. a double blind randomized clinical trial. British Med Anaesthesiology. 2006;12:1471-4.

Lenzhofer R, Moser K. Analgesic effect of tramadol in patients with malignant diseases. Wiener Medizinische Wochenschrift. 1984;134(8):199-202.

Ruoff GE. Slowing the initial titration rate of tramadol improves tolerability. Pharmacotherapy. 1999;19(1):88-93.

Tagarro, I, Herrera J, Barutell C, Diez MC, Marin M, Samper D, et al. Effect of a simple dose-escalation schedule on tramadol tolerability: assessment in the clinical setting. Clinical Drug Investigation. 2005;25(1):23-33.